Recombinant proteins of parapoxvirus ovis and pharmaceutical compositions therefrom
CA 2990079 A1 · Owner: Aicuris Gmbh & Co. Kg · Inventors: Friederichs, Sonja Maria; Siegling, Angela; Fleming, Stephen Bruce
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention relates to polynucleotides coding for the PPVO viral genome to , fragments of , the polynucleotides coding for the PPVO genome and to polynucleotides coding for , individual open reading frames (ORFs) of the PPVO viral genome. The invention also relates , to recombinant proteins expressed from the above mentioned polynucleotides and to , fragments of said recombinant proteins and to the use of said recombinant , proteins or fragments for the preparation of pharmaceutical compositions.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 17, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 17, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 17, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.